Brief: Ascelia Pharma Announces Third Patent Covering Oncoral In USA
13/03/2023 08:06
March 13 (Reuters) - Ascelia Pharma AB ACELP.ST :
* THIRD US PATENT STRENGTHENS PATENT PROTECTION FOR ASCELIA
PHARMA'S ONCORAL (DAILY TABLET IRINOTECAN)
* DECISION OF US PATENT AND TRADEMARK OFFICE (USPTO) TO
ALLOW
ISSUANCE OF A THIRD PATENT COVERING COMPOSITION OF ONCORAL
* NEW PATENT COVERS TABLET COMPOSITION AND WILL PROVIDE
PROTECTION
UNTIL 2035 PLUS POTENTIAL EXTENSION IN US
* OUTSIDE US, ONCORAL IS COVERED BY PATENTS IN SELECTED
EUROPEAN
COUNTRIES AND IN JAPAN, CHINA AND CANADA
Source text for Eikon: ID:nMFN2Sk0jG
Further company coverage: ACELP.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))